Classification of anticancer drugs—a new system based on therapeutic targets

Enrique Espinosa; Pilar Zamora; Jaime Feliú; Manuel González Barón

doi:10.1016/s0305-7372(03)00116-6

Keywords

MedicineMonoclonal antibodyExtracellular matrixCancer researchImmune systemAntibodySmall moleculeCancer cellDNACancerImmunologyCell biologyBiologyBiochemistryInternal medicine

Affiliated Institutions

Hospital Universitario La Paz ES

Related Publications

Molecular Target Class Is Predictive of <i>In vitro</i> Response Profile

Joel Greshock , Kurtis E. Bachman , Yan Degenhardt +9 more

Abstract Preclinical cellular response profiling of tumor models has become a cornerstone in the development of novel cancer therapeutics. As efforts to predict clinical efficac...

2010 Cancer Research 123 citations

Specific apoptosis induction by the dual PI3K/mTor inhibitor NVP-BEZ235 in HER2 amplified and PIK3CA mutant breast cancer cells

Saskia M. Brachmann , Irmgard Hofmann , Christian Schnell +6 more

NVP-BEZ235 is a dual PI3K/mTOR inhibitor currently in phase I clinical trials. We profiled this compound against a panel of breast tumor cell lines to identify the patient popul...

2009 Proceedings of the National Academy o... 316 citations

Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer

Yasutaka Sukawa , Hiroyuki Yamamoto , Katsuhiko Nosho +12 more

HER2 expression, PIK3CA mutations and EBV infection in gastric cancer were characterized. pAkt expression significantly correlates with HER2 expression and with a poor prognosis.

2012 World Journal of Gastroenterology 84 citations

Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of <i>ERBB2</i>

Heidi Greulich , Bethany Kaplan , Philipp Mertins +25 more

We assessed somatic alleles of six receptor tyrosine kinase genes mutated in lung adenocarcinoma for oncogenic activity. Five of these genes failed to score in transformation as...

2012 Proceedings of the National Academy o... 260 citations

mTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPs

Ryan J.O. Dowling , Ivan Topisirović , Tommy Alain +10 more

Proliferation Control The protein complex mTORC1, which contains the protein kinase known as mammalian target of rapamycin, is an important regulator of cell proliferation and c...

2010 Science 745 citations

Publication Info

Year: 2003
Type: review
Volume: 29
Issue: 6
Pages: 515-523
Citations: 173
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Classification of anticancer drugs—a new system based on therapeutic targets

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

173

OpenAlex

Cite This

APA Style

                            
                                
                                    Enrique Espinosa, 
                                
                                    Pilar Zamora, 
                                
                                    Jaime Feliú
                                
                                et al.
                            
                            (2003). 
                            Classification of anticancer drugs—a new system based on therapeutic targets. 
                            Cancer Treatment Reviews
                            , 29
                            (6)
                            , 515-523.
                            https://doi.org/10.1016/s0305-7372(03)00116-6
                        

Identifiers

DOI: 10.1016/s0305-7372(03)00116-6